Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DocGo (DCGO) Total Liabilities (2020 - 2025)

Historic Total Liabilities for DocGo (DCGO) over the last 6 years, with Q3 2025 value amounting to $93.1 million.

  • DocGo's Total Liabilities fell 4489.2% to $93.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $93.1 million, marking a year-over-year decrease of 4489.2%. This contributed to the annual value of $140.4 million for FY2024, which is 2420.05% down from last year.
  • Per DocGo's latest filing, its Total Liabilities stood at $93.1 million for Q3 2025, which was down 4489.2% from $120.5 million recorded in Q2 2025.
  • DocGo's 5-year Total Liabilities high stood at $185.3 million for Q4 2023, and its period low was -$63.9 million during Q1 2023.
  • For the 5-year period, DocGo's Total Liabilities averaged around $96.6 million, with its median value being $106.4 million (2023).
  • As far as peak fluctuations go, DocGo's Total Liabilities surged by 1404011.33% in 2021, and later tumbled by 17521.92% in 2023.
  • DocGo's Total Liabilities (Quarter) stood at $82.5 million in 2021, then skyrocketed by 38.53% to $114.4 million in 2022, then surged by 62.03% to $185.3 million in 2023, then decreased by 24.2% to $140.4 million in 2024, then plummeted by 33.69% to $93.1 million in 2025.
  • Its Total Liabilities stands at $93.1 million for Q3 2025, versus $120.5 million for Q2 2025 and $128.9 million for Q1 2025.